The two faces of IL-6 on Th1/Th2 differentiation.
By S. Diehl, M. Rincón. Molecular Immunology, 2002
892 citations recorded by the source corpus.
Subfields: Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/f70c054ba6cb34dc60d68fd67cdbb6245daef077
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Oncology
Citations in the corpus
- CD4+T Cells: Differentiation and Functions (2012, background): “The inhibition of the Th1 development occurs through the IL6-induced upregulation of suppressor of cytokine signaling-1 (SOCS-1) expression, which interferes with STAT1 activation downstream to IFNγ signaling [49, 50].”
- Cytokines in Inflammatory Disease (2019, background): “Interestingly, IL-6 was first described for its effects on adaptive immunity, like promoting cluster of differentiation (CD)4+ T-cells via IL-21 production, and promoting T-cell differentiation towards T-helper2 cells (Th2) and Th17 cells [24].”
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. (2014, background): “IL-6 is an important modulator to maintain the balance between Th1 and Th2 effector functions (Diehl & Rincon, 2002).”